ReviewCurrent pharmaceutical design2026

Nasal Microbiota as a Potential Therapeutic Target for Allergic Rhinitis: An Emerging Perspective.

Bing-Yu Liang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.